Lilly's Foundao Pill Enters Weight-Loss Race

A.M. Edition for April 2. In a prime-time address to the nation roughly a month into the Iran war, President Trump claims the conflict is nearing an end, even as he says major attacks are still to come. WSJ national security correspondent Shelby Holliday breaks down what Trump said—and didn’t say—about how Washington plans to resolve the crisis in the Strait of Hormuz. Plus, the weight-loss pill battle begins after Eli Lilly’s Foundayo wins U.S. regulatory approval. And reporter Jeanne Whalen explains how nursing could be the new ticket to the elusive American middle class. Luke Vargas hosts.

Sign up for the WSJ’s free What’s News newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices